Literature DB >> 26890489

Complete genome analysis of hepatitis B virus in human immunodeficiency virus infected and uninfected South Africans.

Maemu P Gededzha1, Muxe Muzeze1, Rosemary J Burnett1, Edina Amponsah-Dacosta1, M Jeffrey Mphahlele2, Selokela G Selabe1.   

Abstract

Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections are highly endemic in South Africa. Data on the complete genome sequences of HBV in HIV-positive patients in South Africa are scanty. This study characterized the complete HBV genome isolated from both HIV-positive and negative patients at the Dr George Mukhari Academic Hospital (DGMAH), Pretoria. Serum samples from nine (five HIV-positive and four HIV-negative) patients attending the DGMAH from 2007 to 2011 were serologically tested, amplified, and sequenced for complete genome. Phylogenetic tree was constructed using MEGA6.0. Mutations were analyzed by comparing the sequences with genotype-matched GenBank references. Eight patients were HBsAg positive, with only one from the HIV positive group being negative. Phylogenetic analysis of the complete genome sequences classified them into five genotypes; A1 (n = 4), A2 (n = 1), C1 (n = 2), D1 (n = 1), and D3 (n = 1). Deletions up to 35 nucleotides in length were identified in this study. No drug resistance mutations were identified in the P ORF, while the L217R mutation was identified in one subgenotype A2 sequence. The double (A1762T/G1764A) and triple (T1753C/A1762T/G1764A) mutations in the Basal core promoter were identified in four and two sequences, respectively. In the core region, mutation G1888A was identified in four of the subgenotype A1 sequences. In conclusion, this study has added to the limited South African data on HBV genotypes and mutations in HBV/HIV co-infected and HBV mono-infected patients, based on complete HBV genome analysis. Subgenotype A1 was predominant, and no drug-resistant mutants were detected in the study. J. Med. Virol. 88:1560-1566, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  HBV complete genome; HBV subgenotype A; HIV positive; mutations

Mesh:

Substances:

Year:  2016        PMID: 26890489     DOI: 10.1002/jmv.24502

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  4 in total

1.  The genotype analysis of the hepatitis C virus in Heilongjiang Province, China.

Authors:  Xue-Di Cheng; Hua-Feng Xu; Feng Wei; Li-Xin Jiang; Hai-Zhou Zhou
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

2.  Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.

Authors:  Mikael Gencay; Kirsten Hübner; Peter Gohl; Anja Seffner; Michael Weizenegger; Dionysios Neofytos; Richard Batrla; Andreas Woeste; Hyon-Suk Kim; Gaston Westergaard; Christine Reinsch; Eva Brill; Pham Thi Thu Thuy; Bui Huu Hoang; Mark Sonderup; C Wendy Spearman; Stephan Pabinger; Jérémie Gautier; Giuseppina Brancaccio; Massimo Fasano; Teresa Santantonio; Giovanni B Gaeta; Markus Nauck; Wolfgang E Kaminski
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

3.  A novel hepatitis B virus recombinant genotype D4/E identified in a South African population.

Authors:  Mmatsatsi K Matlou; Lucinda R Gaelejwe; Andrew M Musyoki; J Nare Rakgole; Selokela G Selabe; Edina Amponsah-Dacosta
Journal:  Heliyon       Date:  2019-04-06

4.  A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action.

Authors:  Jolynne Mokaya; Anna L McNaughton; Martin J Hadley; Apostolos Beloukas; Anna-Maria Geretti; Dominique Goedhals; Philippa C Matthews
Journal:  PLoS Negl Trop Dis       Date:  2018-08-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.